The World Cancer Research Fund is launching a pan-European PR and
lobbying campaign to promote its findings on the link between diet and
The charity has hired the public affairs company GPC Connect and its
European office GPC Market Access Europe in Brussels to manage the
The fund, part of the American Cancer Research Institute, has briefed
GPC to target civil servants and health ministers in a bid to get diet
linked with cancer in the annual progress report of the government’s
Health of the Nation target.
GPC’s PR partner Countrywide Communications has been appointed to get
global media coverage for the findings of the fund’s study, to be
released in May 1997.
GPC Connect has also been appointed by Glaxo Wellcome to run an
international lobbying drive to delay the ban on metered dose inhalers
(MDIs) as used by asthma sufferers. The Montreal Protocol, an
international agreement, banned CFC use by 1 January 1996 with the
exception of MDIs.
Glaxo Wellcome is hoping to delay an eventual ban on MDIs to allow it
time to develop alternatives. Rival 3M Pharmaceuticals has already
developed a non-CFC MDI.
GPC Connect’s campaign will aim to advise local operating companies how
to lobby their member states.
The combined fee income for both campaigns, which will run initially
until the end of the year, is around pounds 40,000.